Jian Lei

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 10

Top Topics

Protein Protein

Respiratory Syndrome Coronavirus

Top Venues

Signal transduction and targeted therapy

Communications biology

Science (New York, N.Y.)

Nature microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Chong Huang, Huiping Shuai, Jingxin Qiao, Yuxin Hou, Rui Zeng, An-Jie Xia, Lingwan Xie, Zhen Fang, Yueyue Li, Chaemin Yoon, Qiao Huang, Bingjie Hu, Jing You, Baoxue Quan, Xiu Zhao, Nihong Guo, Shiyu Zhang, Ronggang Ma, Jiahao Zhang, Yifei Wang, Ruicheng Yang, Shanshan Zhang, Jinshan Nan, Haixing Xu, Falu Wang, Jian Lei, Hin Chu, Shengyong Yang
A new generation M pro inhibitor with potent activity against SARS-CoV-2 Omicron variants. Signal transduction and targeted therapy 8 (1) (2023)
Chong Huang, Huiping Shuai, Jingxin Qiao, Yuxin Hou, Rui Zeng, An-Jie Xia, Lingwan Xie, Zhen Fang, Yueyue Li, Chaemin Yoon, Qiao Huang, Bingjie Hu, Jing You, Baoxue Quan, Xiu Zhao, Nihong Guo, Shiyu Zhang, Ronggang Ma, Jiahao Zhang, Yifei Wang, Ruicheng Yang, Shanshan Zhang, Jinshan Nan, Haixing Xu, Falu Wang, Jian Lei, Hin Chu, Shengyong Yang
A new generation M pro inhibitor with potent activity against SARS-CoV-2 Omicron variants. Signal transduction and targeted therapy 8 (1) (2023)
Xincheng Ni, Yinze Han, Renjie Zhou, Yanmei Zhou, Jian Lei
Structural insights into ribonucleoprotein dissociation by nucleocapsid protein interacting with non-structural protein 3 in SARS-CoV-2. Communications biology 6 (1) (2023)
Chong Huang, Huiping Shuai, Jingxin Qiao, Yuxin Hou, Rui Zeng, An-Jie Xia, Lingwan Xie, Zhen Fang, Yueyue Li, Chaemin Yoon, Qiao Huang, Bingjie Hu, Jing You, Baoxue Quan, Xiu Zhao, Nihong Guo, Shiyu Zhang, Ronggang Ma, Jiahao Zhang, Yifei Wang, Ruicheng Yang, Shanshan Zhang, Jinshan Nan, Haixing Xu, Falu Wang, Jian Lei, Hin Chu, Shengyong Yang
A new generation M pro inhibitor with potent activity against SARS-CoV-2 Omicron variants. Signal transduction and targeted therapy 8 (1) (2023)
Xincheng Ni, Yinze Han, Renjie Zhou, Yanmei Zhou, Jian Lei
Structural insights into ribonucleoprotein dissociation by nucleocapsid protein interacting with non-structural protein 3 in SARS-CoV-2. Communications biology 6 (1) (2023)
Xincheng Ni, Yinze Han, Renjie Zhou, Yanmei Zhou, Jian Lei
Structural insights into ribonucleoprotein dissociation by nucleocapsid protein interacting with non-structural protein 3 in SARS-CoV-2. Communications biology 6 (1) (2023)
Chong Huang, Huiping Shuai, Jingxin Qiao, Yuxin Hou, Rui Zeng, An-Jie Xia, Lingwan Xie, Zhen Fang, Yueyue Li, Chaemin Yoon, Qiao Huang, Bingjie Hu, Jing You, Baoxue Quan, Xiu Zhao, Nihong Guo, Shiyu Zhang, Ronggang Ma, Jiahao Zhang, Yifei Wang, Ruicheng Yang, Shanshan Zhang, Jinshan Nan, Haixing Xu, Falu Wang, Jian Lei, Hin Chu, Shengyong Yang
A new generation M pro inhibitor with potent activity against SARS-CoV-2 Omicron variants. Signal transduction and targeted therapy 8 (1) (2023)
Xincheng Ni, Yinze Han, Renjie Zhou, Yanmei Zhou, Jian Lei
Structural insights into ribonucleoprotein dissociation by nucleocapsid protein interacting with non-structural protein 3 in SARS-CoV-2. Communications biology 6 (1) (2023)
Bao-Xue Quan, Huiping Shuai, An-Jie Xia, Yuxin Hou, Rui Zeng, Xin-Lei Liu, Gui-Feng Lin, Jing-Xin Qiao, Wen-Pei Li, Fa-Lu Wang, Kai Wang, Ren-Jie Zhou, Terrence Tsz-Tai Yuen, Ming-Xin Chen, Chaemin Yoon, Ming Wu, Shi-Yu Zhang, Chong Huang, Yi-Fei Wang, Wei Yang, Chenyu Tian, Wei-Min Li, Yu-Quan Wei, Kwok-Yung Yuen, Jasper Fuk-Woo Chan, Jian Lei, Hin Chu, Sheng-Yong Yang
An orally available M pro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron. Nature microbiology 7 (5) (2022)
Jingxin Qiao, Yue-Shan Li, Rui Zeng, Feng-Liang Liu, Rong-Hua Luo, Chong Huang, Yi-Fei Wang, Jie Zhang, Baoxue Quan, Chenjian Shen, Xin Mao, Xinlei Liu, Weining Sun, Wei Yang, Xincheng Ni, Kai Wang, Ling Xu, Zi-Lei Duan, Qing-Cui Zou, Hai-Lin Zhang, Wang Qu, Yang-Hao-Peng Long, Ming-Hua Li, Rui-Cheng Yang, Xiaolong Liu, Jing You, Yangli Zhou, Rui Yao, Wen-Pei Li, Jing-Ming Liu, Pei Chen, Yang Liu, Gui-Feng Lin, Xin Yang, Jun Zou, Linli Li, Yiguo Hu, Guang-Wen Lu, Wei-Min Li, Yu-Quan Wei, Yong-Tang Zheng, Jian Lei, Sheng-Yong Yang
SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model. Science (New York, N.Y.) 371 (6536) (2021)